This is the authors' abstract. We don't add key points for this paper.
and UBE2C increase. Furthermore, simultaneous WDR76 knockdown via adeno-associated virus (AAV) injection into the pancreatic duct fully rescues RAS/ERK inactivation and PDAC suppression caused by Ube2c deletion, demonstrating a causal role of the UBE2C-WDR76 axis. Collectively, these findings suggest that the UBE2C-WDR76 axis may represent a promising therapeutic target for the treatment of KRAS-driven pancreatic cancer.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: